Log In
Print this Print this

Angeliq, drospirenone/estradiol

  Manage Alerts
Collapse Summary General Information
Company Bayer AG
DescriptionOnce-daily combination of drospirenone, an estrogen, and estradiol, a progestin.
Molecular Target Estrogen receptor 1 (ESR1) ; Progesterone receptor (PGR)
Mechanism of ActionUnknown
Therapeutic ModalitySmall molecule: Combination
Latest Stage of DevelopmentMarketed
Standard IndicationMenopause
Indication DetailsTreat menopausal symptoms
Regulatory Designation

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today